Sale

Sweet Island Skunk CBD small buds

Original price was: $350.Current price is: $300.

Sweet Island Skunk CBD Small Buds (also widely distributed as Island Sweet Skunk CBD) is an uplifting sativa-dominant therapeutic hemp cultivar bred by crossing Vancouver Island heritage clone Island Sweet Skunk (Sweet Pink Grapefruit × Big Skunk #1) with certified high-cannabidiol European breeding stock. Grown under strict GACP agricultural protocols and packaged within EU-GMP certified cleanrooms, this “small buds” (popcorn calyx) selection isolates uniform 10 mm to 20 mm mini-buds that preserve identical secondary metabolite concentrations to prime top colas. Emitting a vibrant bouquet of tart pink grapefruit, ripe tropical mango, pungent skunk, and crisp alpine pine, Sweet Island Skunk CBD delivers daytime therapeutic clarity verified by ISO/IEC 17025 accredited pharmacopoeial testing

Sweet Island Skunk originated in British Columbia, Canada, earning international acclaim for its high monoterpene accumulation and energetic sativa qualities derived from Sweet Pink Grapefruit and Skunk #1 genetics. By backcrossing this elite clone with stabilized European industrial hemp chemotypes, breeders retained the distinct tropical citrus and sulfur-skunk profile while stabilizing total THC levels strictly below statutory non-narcotic thresholds.

This specialized Small Buds release provides an economical bulk format for European licensed pharmacies, clinical compounding facilities, and institutional wholesale distribution. Screened post-cure through calibrated pharmaceutical-grade stainless steel sorters to isolate dense 10 mm to 20 mm calyx clusters, these lower- and mid-canopy buds feature minimal woody stem mass while maintaining full secondary metabolite accumulation. Across European medical markets—notably Germany under the CanG framework, Austria, the United Kingdom, and Poland—Sweet Island Skunk CBD is commonly dispensed for daytime anxiety, chronic fatigue, depressive mood states, migraine relief, and stress-related tension without psychoactive impairment.

Technical Specifications & Certificate of Analysis (CoA)

Specification Standard / Analytical Value
Cultivar Lineage Sweet Island Skunk (Sweet Pink Grapefruit × Big Skunk #1) × Certified EU Hemp
Botanical Classification Sativa-dominant Hybrid (~75/25)
Flower Grading Calibrated Small Buds / Popcorn Calyxes (10 mm – 20 mm diameter)
Total CBD Potency 12.0% – 16.0% w/w (CBD + 0.877 × CBDA)
Total THC Potency < 0.20% – 0.30% w/w (Fully compliant with EU Regulation 2021/2115)
Minor Cannabinoids CBG (0.7% – 1.5%), CBC (0.3% – 0.8%), CBDV (0.2% – 0.5%), CBN (< 0.05%)
Primary Terpenes Myrcene, Alpha-Pinene, D-Limonene, Beta-Caryophyllene
Total Terpene Content 2.0% – 3.6% dry weight
Moisture Content 8.0% – 11.5% (Ph. Eur. 2.2.32)
Treatment / Decontamination Beta-Irradiated / E-Beam / Non-Irradiated lots available
Cultivation Standard GACP (Good Agricultural and Collection Practice)
Manufacturing Standard EU-GMP (Good Manufacturing Practice Part I & II)
Pharmacopoeial Monograph European Pharmacopoeia (Ph. Eur.) Monograph 3028

Sensory & Terpene Profile Breakdown

  • Candied Grapefruit & Tropical Nectar: Dominated by a balanced synergy of D-Limonene and Myrcene, releasing an immediate burst of tart ruby red grapefruit, fresh mango pulp, and sweet citrus rind upon handling.

  • Pungent Skunk & Herbal Musk: Inherited directly from its Skunk #1 parent, volatile organic sulfur compounds deliver an unmistakable earthy skunk and musk pungency upon grinding.

  • Crisp Mountain Pine & Alpine Air: Alpha-Pinene introduces a cooling, resinous conifer-needle freshness that opens respiratory pathways during thermal vaporization.

  • Warm Spiced Sandalwood: Beta-Caryophyllene provides an earthy back-note of cracked black pepper and cedar that grounds the effervescent citrus top notes.

  • Visual Morphology: Compact, tightly manicured, thumbnail-sized bright lime-green nuggets with golden highlights, laced with vivid tangerine pistils and a thick frost of mature glandular trichome heads.

European Compliance, Quality Assurance & Distribution

  • EU-GMP Quality Assurance: Cured, mechanically sized, and packaged in certified pharmaceutical cleanrooms operating under EU-GMP parameters, ensuring lot-to-lot homogeneity, minimal stem ratio, and zero foreign matter.

  • Non-Narcotic Regulatory Clearance: Derived exclusively from industrial hemp varieties registered in the EU Common Catalogue of Plant Species and verified to contain total THC concentrations below statutory member-state limits (< 0.2% / < 0.3% w/w). Classified as a non-controlled botanical raw material suitable for cross-border commercial transport across EU/EEA member states.

  • Accredited Laboratory Testing: Fully analyzed by independent third-party ISO/IEC 17025 accredited analytical laboratories in strict compliance with Ph. Eur. Chapter 5.1.8, certifying the absence of heavy metals (lead, arsenic, cadmium, mercury), agrochemical residues, aflatoxins, and microbial pathogens.

  • Schengen Cross-Border Logistics: Supported by an end-to-end regulatory compliance pack, including batch-specific Certificates of Analysis (CoAs), active pharmaceutical ingredient (API) declarations, technical data sheets (TDS), and commercial intra-EU transport manifests.

  • Medical Packaging Integrity: Sealed in light-blocking, food- and pharma-grade foil pouches or airtight medical glass containers under nitrogen flushing, equipped with integrated 62% relative humidity control sachets to preserve volatile monoterpenes and maintain optimal calyx density during transit and shelf life.

— BE THE FIRST TO SEE THE LATEST DEAL AND OFFERS —

Join Our WhatsApp
Community